According to reports from Marketbeat.com, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares have been given a consensus rating of "Buy" by the fourteen rating...
The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...